Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Uncover where to find quick cash gigs that suit your skills. Start earning today with accessible opportunities!
20,284 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
When Micron stock sinks today, it isn’t just one factor at play. This guide breaks down the drivers, how to read the ...
Netflix has shown strong momentum, but a stock price path hinges on more than business strength. This article breaks ...
U.S. stocks drifted midweek as analysts rolled out fresh price targets on key names. Here’s a look at Wednesday’s top...
Two AI powerhouses are forming a rare alliance to chase a massive market. This article explains the rationale, potent...
Since 2020, five magnificent stocks have split their shares. Only Alphabet and Tesla outpaced the market, proving tha...
CrowdStrike forms a strategic tie-up with Nebius Group to integrate Falcon security into Nebius AI Cloud, while repor...
The Federal Reserve keeps policy unchanged as global tensions weigh on growth and inflation prospects. The move delay...
Oil prices stay elevated, lifting a near-term windfall for U.S. producers by roughly $63 billion. But a protracted Ir...
Trinity Capital remains a high-yield fixture in venture lending, but a balance of losses, dilution, and rate shifts u...
Oklo’s latest move—acquiring Atomic Alchemy—signals more than a strategic expansion. This article breaks down what it...
Apollo Global Management posted strong 2025 revenue and raised its dividend, but the stock has fallen as private cred...